EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers

Shin Ito, Mika Ando, Shuichi Aoki, Satoshi Soma, Jie Zhang, Naohiro Hirano, Ryosuke Kashiwagi, Keigo Murakami, Shingo Yoshimachi iD, Hideaki Sato, Akiko Kusaka, Masahiro Iseki und 8 weitere

Cancer Science · 2024-12 · 115 (12) · 4054-4063

DOI: 10.1111/cas.16365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 08.10.2024. Verfasst von Shin Ito und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Bile, Mutation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsy (LB) is an essential tool for obtaining tumor‐derived materials with minimum invasion. Bile has been shown to contain much higher free nucleic acid levels than blood plasma and can be collected through endoscopic procedures. Therefore, bile possesses high potential as a source of tumor derived cell‐free DNA (cfDNA) for bile duct cancers. In this study, we show that a multigene panel for plasma LB can also be applied to bile cfDNA for comparing driver gene mutation detection in other sources (plasma and tumor tissues of the corresponding patients). We collected cfDNA samples from the bile of 24 biliary tract cancer cases. These included 17 cholangiocarcinomas, three ampullary carcinoma, two pancreatic cancers, one intraductal papillary mucinous carcinoma, and one insulinoma. Seventeen plasma samples were obtained from the corresponding patients before surgical resection and subjected to the LiquidPlex multigene panel LB system. We applied a machine learning approach to classify possible tumor‐derived variants among the prefiltered variant calls by a LiquidPlex analytical package with high fidelity. Among the 17 cholangiocarcinomas, we could detect cancer driver mutations in the bile of 10 cases using the LiquidPlex system. Of the biliary tract cancer cases examined with this method, 13 (54%) and 4 (17%) resulted in positive cancer driver mutation detection in the bile and plasma cfDNAs, respectively. These results suggest that bile is a more reliable source for LB than plasma for multigene panel analyses of biliary tract cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsBileMutationHumansLiquid BiopsyMaleFemaleAgedMiddle AgedCholangiocarcinomaAged, 80 and overBiomarkers, TumorCirculating Tumor DNACell-Free Nucleic AcidsMachine Learning

Stichwörter der Autor:innen

bilebiliary duct cancerliquid biopsymachine learningmultigene panel

Substanzen

Biomarkers, TumorCirculating Tumor DNACell-Free Nucleic Acids

Autor:innen und Institutionen

  • Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
  • Division of Cancer Molecular Biology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.

ORCID-Profile: Shingo Yoshimachi, Kei Nakagawa, Jun Yasuda, Michiaki Unno

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ito, S., Ando, M., Aoki, S., Soma, S., Zhang, J., Hirano, N., Kashiwagi, R., Murakami, K., Yoshimachi, S., Sato, H., Kusaka, A., Iseki, M., Inoue, K., Mizuma, M., Kume, K., Nakagawa, K., Masamune, A., Asano, N., Yasuda, J., & Unno, M. (2024). Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers. Cancer Science, 115(12), 4054-4063. https://doi.org/10.1111/cas.16365

Vancouver

Ito S, Ando M, Aoki S, Soma S, Zhang J, Hirano N, et al. Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers. Cancer Science. 2024;115(12):4054-4063. doi:10.1111/cas.16365

BibTeX
@article{Ito2024,
  author = {Ito, Shin and Ando, Mika and Aoki, Shuichi and Soma, Satoshi and Zhang, Jie and Hirano, Naohiro and Kashiwagi, Ryosuke and Murakami, Keigo and Yoshimachi, Shingo and Sato, Hideaki and Kusaka, Akiko and Iseki, Masahiro and Inoue, Koetsu and Mizuma, Masamichi and Kume, Kiyoshi and Nakagawa, Kei and Masamune, Atsushi and Asano, Naoki and Yasuda, Jun and Unno, Michiaki},
  title = {Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers},
  journal = {Cancer Science},
  year = {2024},
  volume = {115},
  number = {12},
  pages = {4054--4063},
  doi = {10.1111/cas.16365}
}
Kostenlos starten →